Dr. Barry Byrne Named Innovator of the Year
The annual event honored Dr. Barry Byrne as Innovator of the Year for his contributions to gene therapy and highlighted six teams of inventors for their Inventions of the Year.
Here’s How AI Could Bring Better Fruit to Your Table
Researchers at the University of Florida envision a quicker method: exploring the natural variations in plant genetics using artificial intelligence. The applications extend far beyond blueberries, a growing sector of Florida’s $182.6 billion agriculture industry. Their brainchild, the AI Connoisseur, would not only give Florida farms an edge, but make healthy food more palatable to more people, bringing varieties with heirloom-quality flavor within everyone’s reach. All they’d have to do is teach a computer to taste.
$12.6 Million Department of Energy Grant Funds Advanced Quantum Research Center
The Center for Molecular Magnetic Quantum Materials at the University of Florida has received a $12.6 million, four-year grant from the U.S. Department of Energy to continue its work developing next-generation quantum materials for advanced applications in computing and energy.
UF Researchers Find New Sugar Substitutes in Citrus That Could Change Food and Beverage Industry
Finding natural, non-caloric sugar substitutes is desirable but challenging. However, researchers at the University of Florida Institute of Food and Agricultural Sciences have made a breakthrough — discovering new, natural sweeteners in citrus for the first time.
New HiPerGator Simulations “Solve Mother Nature” To Address Real-World Problems
In one of the most intensive uses yet of the University of Florida’s HiPerGator supercomputer, UF engineers have faithfully reproduced the turbulence and complexity of hot air rising along a wall — a previously impossible simulation with applications in home fire safety and heating and cooling.
UF Health Researcher Aims To Create AI Algorithm To Help Map Human Body’s Cells
Recently hired UF College of Medicine faculty member Pinaki Sarder, Ph.D., is leading a project where researchers at UF Health are developing an artificial intelligence algorithm to be used by scientists around the nation who are mapping out the entire human body at the single-cell level.
UF Accelerate Residents Announced As Finalists for the 12th Annual GrowFL Florida Companies To Watch
UF Accelerate | Sid Martin Biotech resident Neobiosis, and UF Accelerate | The Hub resident Quottly, have been selected as finalists for this year's annual GrowFL Florida companies to watch.
CEO of UF Startup AxoGen is appointed to EyePoint Pharmaceuticals Board of Directors
EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.
Leaders in Agriculture and Aerospace Partner To Create Rapid Crop Evaluation for Farmers
SATLANTIS LLC (SATLANTIS) and Agriculture Intelligence, Inc (AgIntel) announced a collaborative initiative with leading industry experts to combine agriculture intelligence and high resolution satellite monitoring with hopes to enhance current crop evaluation techniques for growers significantly. In late May, SATLANTIS successfully launched a satellite from the Cape Canaveral Force Station on board a SpaceX Falcon 9 rocket.
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’s HPV/Gardasil Franchise. Ms. Murphy joined Oragenics’ Board of Directors in 2020.
